Impact of TRIM5α in vivo
- PMID: 26372380
- PMCID: PMC4568895
- DOI: 10.1097/QAD.0000000000000812
Impact of TRIM5α in vivo
Abstract
HIV type 1 (HIV-1) has a very narrow host range that is limited to humans and chimpanzees. HIV-1 cannot replicate well in Old World monkey cells such as rhesus and cynomolgus monkeys. Tripartite motif (TRIM)5α is a key molecule that confers potent resistance against HIV-1 infection and is composed of really interesting new gene, B-box2, coiled-coil and PRYSPRY domains. Interaction between TRIM5α PRYSPRY domains and HIV-1 capsid core triggers the anti-HIV-1 activity of TRIM5α. Analysis of natural HIV variants and extensive mutational experiments has revealed the presence of critical amino acid residues in both the PRYSPRY domain and HIV capsid for potent HIV suppression by TRIM5α. Genetic manipulation of the human TRIM5 gene could establish human cells totally resistant to HIV-1, which may lead to a cure for HIV-1 infection in the future.
Figures
![Fig. 1](https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b0d5/4568895/ade6edcddbd8/aids-29-1733-g001.gif)
![Fig. 2](https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b0d5/4568895/868f70a51156/aids-29-1733-g002.gif)
![Fig. 3](https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b0d5/4568895/e54c7966bae6/aids-29-1733-g003.gif)
![Fig. 4](https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b0d5/4568895/3d7f13967e5b/aids-29-1733-g004.gif)
![Fig. 5](https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b0d5/4568895/5c5428701c78/aids-29-1733-g005.gif)
![Fig. 6](https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b0d5/4568895/653a8af6f5e0/aids-29-1733-g006.gif)
Similar articles
-
Functional replacement of the RING, B-box 2, and coiled-coil domains of tripartite motif 5alpha (TRIM5alpha) by heterologous TRIM domains.J Virol. 2006 Jul;80(13):6198-206. doi: 10.1128/JVI.00283-06. J Virol. 2006. PMID: 16775307 Free PMC article.
-
Anti-retroviral activity of TRIM5 alpha.Rev Med Virol. 2010 Mar;20(2):77-92. doi: 10.1002/rmv.637. Rev Med Virol. 2010. PMID: 20049904 Review.
-
Binding of the rhesus TRIM5α PRYSPRY domain to capsid is necessary but not sufficient for HIV-1 restriction.Virology. 2014 Jan 5;448:217-28. doi: 10.1016/j.virol.2013.10.012. Epub 2013 Oct 31. Virology. 2014. PMID: 24314652 Free PMC article.
-
TRIM5α and Species Tropism of HIV/SIV.Front Microbiol. 2012 Jan 24;3:13. doi: 10.3389/fmicb.2012.00013. eCollection 2012. Front Microbiol. 2012. PMID: 22291694 Free PMC article.
-
[TRIM5alpha].Uirusu. 2005 Dec;55(2):259-65. doi: 10.2222/jsv.55.259. Uirusu. 2005. PMID: 16557011 Review. Japanese.
Cited by
-
The roles and targeting options of TRIM family proteins in tumor.Front Pharmacol. 2022 Sep 30;13:999380. doi: 10.3389/fphar.2022.999380. eCollection 2022. Front Pharmacol. 2022. PMID: 36249749 Free PMC article. Review.
-
Emergence and molecular mechanisms of SARS-CoV-2 and HIV to target host cells and potential therapeutics.Infect Genet Evol. 2020 Nov;85:104583. doi: 10.1016/j.meegid.2020.104583. Epub 2020 Oct 6. Infect Genet Evol. 2020. PMID: 33035643 Free PMC article. Review.
-
Delayed disease progression in HIV-2: the importance of TRIM5α and the retroviral capsid.Clin Exp Immunol. 2019 Jun;196(3):305-317. doi: 10.1111/cei.13280. Epub 2019 Mar 21. Clin Exp Immunol. 2019. PMID: 30773620 Free PMC article. Review.
-
SAMHD1 expression is associated with low immune activation but not correlated with HIV‑1 DNA levels in CD4+ T cells of patients with HIV‑1.Mol Med Rep. 2020 Aug;22(2):879-885. doi: 10.3892/mmr.2020.11153. Epub 2020 May 18. Mol Med Rep. 2020. PMID: 32468062 Free PMC article.
-
Restriction of HIV-1 and other retroviruses by TRIM5.Nat Rev Microbiol. 2019 Sep;17(9):546-556. doi: 10.1038/s41579-019-0225-2. Epub 2019 Jul 16. Nat Rev Microbiol. 2019. PMID: 31312031 Free PMC article. Review.
References
-
- Harris RS, Bishop KN, Sheehy AM, Craig HM, Petersen-Mahrt SK, Watt IN, et al. DNA deamination mediates innate immunity to retroviral infection. Cell 2003; 113:803–809. - PubMed
-
- Mangeat B, Turelli P, Caron G, Friedli M, Perrin L, Trono D. Broad antiretroviral defence by human APOBEC3G through lethal editing of nascent reverse transcripts. Nature 2003; 424:99–103. - PubMed
-
- Sheehy AM, Gaddis NC, Choi JD, Malim MH. Isolation of a human gene that inhibits HIV-1 infection and is suppressed by the viral Vif protein. Nature 2002; 418:646–650. - PubMed
-
- Mariani R, Chen D, Schrofelbauer B, Navarro F, Konig R, Bollman B, et al. Species-specific exclusion of APOBEC3G from HIV-1 virions by Vif. Cell 2003; 114:21–31. - PubMed
-
- Marin M, Rose KM, Kozak SL, Kabat D. HIV-1 Vif protein binds the editing enzyme APOBEC3G and induces its degradation. Nat Med 2003; 9:1398–1403. - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources